Consequences of drug binding to immune receptors: Immune stimulation following pharmacological interaction with immune receptors (T-cell receptor for antigen or human leukocyte antigen) with altered peptide-human leukocyte antigen or peptide

Dermatologica Sinica

Volumn 31, Issue 4, 2013, Pages 181-190

  Pichler, Werner J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

abacavir; altered peptide concept; altered pHLA concept; carbamazepine; flucloxacillin; haptens; p i concept; p i HLA; p i TCR; sulfamethoxazole

Indexed keywords

ABACAVIR; ALLOPURINOL; CARBAMAZEPINE; FLUCLOXACILLIN; HAPTEN; HLA ANTIGEN; SULFAMETHOXAZOLE; T LYMPHOCYTE RECEPTOR;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; DRESS SYNDROME; DRUG BINDING; DRUG HYPERSENSITIVITY; HAPTEN CARRIER COMPLEX; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; MACULOPAPULAR RASH; PROTEIN BINDING; REVIEW; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

EID: 84887317009     PISSN: 10278117     EISSN: 2223330X     Source Type: Journal    
DOI: 10.1016/j.dsi.2013.09.005     Document Type: Review

References (62)

1. T.L. Wagner, C.L. Ahonen, and A.M. Couture Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod Cell Immunol 191 1999 10 19
2. K. Dickhaut, S. Hoepner, and J. Eckhard Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE) PLoS One 4 2009 e6811
3. M.A. Norcross, S. Luo, and L. Lu Abacavir induces loading of novel self-peptides into HLA-Bâ̂ - 57: 01: an autoimmune model for HLA-associated drug hypersensitivity AIDS 26 2012 F21 F29
4. P.T. Illing, J.P. Vivian, and N.L. Dudek Immune self-reactivity triggered by drug-modified HLA-peptide repertoire Nature 486 2012 554 558
5. D.A. Ostrov, B.J. Grant, and Y.A. Pompeu Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire Proc Natl Acad Sci U S A 109 2012 9959 9964
6. S. von Greyerz, M. Zanni, K. Frutig, B. Schyder, and W.J. Pichler Interaction of sulfonamide-derivatives with the TCR of sulfamethoxazole specific αβ+ T cell clones J Immunol 162 1999 595 602
7. D.A. Schmid, J.P.H. Depta, M. Lüthi, and W.J. Pichler Transfection of drug specific T cell receptors into hybridoma cells: tools to monitor drug binding to TCR and to evaluate cross-reactivity to related compounds Mol Pharmacol 70 2006 356 365
8. W.J. Pichler Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept Curr Opin Allergy Clin Immunol 2 2002 301 305
9. W.J. Pichler, A. Beeler, and M. Keller Pharmacological interaction of drugs with immune receptors: the p-i concept Allergol Int 55 2006 17 25
10. W.J. Pichler Delayed drug hypersensitivity reactions Ann Intern Med 139 2003 683 693
11. O.T. Avery, and W.F. Goebel Chemo-immunological studies on conjugated carbohydrate-proteins: II. Immunological specificity of synthetic sugar-protein antigens J Exp Med 50 1929 533 550
12. K. Landsteiner, and J. van der Scheer Serological reactions with simple chemical compounds (precipitin reactions) J Exp Med 56 1932 399 409
13. S. El-Ghaiesh, M.M. Monshi, and P. Whitaker Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis J Pharmacol Exp Ther 341 2012 597 610
14. K. Landsteiner, and M.W. Chase Studies on the sensitization of animals with simple chemical compounds: IX. Skin Sensitization induced by injection of conjugates J Exp Med 73 1941 431 438
15. H.U. Weltzien, C. Moulon, S. Martin, E. Padovan, U. Hartmann, and J. Kohler T cell immune responses to haptens. Structural models for allergic and autoimmune reactions Toxicology 107 1996 141 151
16. S. Aiba Maturation of dendritic cells induced by cytokines and haptens Tohoku J Exp Med 184 1998 159 172
17. R. Megherbi, E. Kiorpelidou, and B. Foster Role of protein haptenation in triggering maturation events in the dendritic cell surrogate cell line THP-1 Toxicol Appl Pharmacol 238 2009 120 132
18. P. Griem, M. Wulferink, B. Sachs, J.B. González, and E. Gleichmann Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today 19 1998 133 139
19. J.P. Sanderson, D.J. Naisbitt, and J. Farrell Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell stimulatory signaling J Immunol 178 2007 5533 5542
20. M.J. Rieder, J. Uetrecht, N.H. Shear, and S.P. Spielberg Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides J Pharmacol Exp Ther 244 1988 724 728
21. Z. Spanou, M. Keller, and M. Britschgi Involvement of drug-specific T cells in acute drug-induced interstitial nephritis J Am Soc Nephrol 17 2006 2919 2927
22. J. Adam, W.J. Pichler, and D. Yerly Delayed drug hypersensitivity: models of T-cell stimulation Br J Clin Pharmacol 71 2011 701 707
23. B. Schnyder, D. Mauri-Hellweg, M. Zanni, F. Bettens, and W.J. Pichler Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones J Clin Invest 100 1997 136 141
24. D. Mauri-Hellweg, F. Bettens, D. Mauri, C. Brander, T. Hunziker, and W.J. Pichler Activation of drug specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin and carbamazepine J Immunol 155 1995 462 472
25. M.P. Zanni, S. von Greyerz, and B. Schnyder HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes J Clin Invest 102 1998 1591 1598
26. C. Burkhart, M. Britschgi, and I. Strasser Non-covalent presentation of sulfamethoxazole to human CD4+ T cells is independent of distinct human leucocyte antigen-bound peptides Clin Exp Allergy 32 2002 1635 1643
27. C. Brander, D. Mauri-Hellweg, H.P. Rolli, M. Goldman, and W.J. Pichler Heterogeneous T cell responses to b-lactam modified self structures are observed in penicillin-allergic individuals J Immunol 155 1995 2670 2678
28. D. Mauri-Hellweg, M. Zanni, and E. Frei Crossreactivity of T cell lines and clones to beta-lactam antibiotics J Immunol 157 1996 1071 1079
29. E. Padovan, D. Mauri-Hellweg, W.J. Pichler, and H.U. Weltzien T cell recognition of penicillin G: structural features determining antigenic specificity Eur J Immunol 26 1996 42 48
30. M.P. Zanni, D. Mauri-Hellweg, and C. Brander Characterization of lidocaine-specific T cells J Immunol 158 1997 1139 1148
31. M.P. Zanni, S. von Greyerz, Y. Hari, B. Schnyder, and W.J. Pichler Recognition of local anesthetics by alphabeta+ T cells J Invest Dermatol 112 1999 197 204
32. J. Adam, K.K. Eriksson, B. Schnyder, S. Fontana, W.J. Pichler, and D. Yerly Avidity determines T-cell reactivity in abacavir hypersensitivity Eur J Immunol 42 2012 1 11
33. J.P. Depta, F. Altznauer, K. Gamerdinger, C. Burkhart, H.U. Weltzien, and W.J. Pichler Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity J Allergy Clin Immunol 113 2004 519 527
34. W.J. Pichler Lessons from drug allergy: against dogmata Curr Allergy Asthma Rep 3 2003 1 3
35. S. von Greyerz, G. Bultemann, and K. Schnyder Degeneracy and additional alloreactivity of drug-specific human alpha beta(+) T cell clones Int Immunol 13 2001 877 885
36. Y. Wu, J. Farrell, M. Pirmohamed, B.K. Park, and D.J. Naisbitt Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity J Allergy Clin Immunol 119 2007 973 981
37. D.J. Naisbitt, J. Farrell, and G. Wong Characterization of drug-specific T cells in lamotrigine hypersensitivity J Allergy Clin Immunol 111 2003 1393 1403
38. B. Schnyder, K. Frutig, D. Mauri-Hellweg, A. Limat, N. Yawalkar, and W.J. Pichler T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazole-induced skin reaction Clin Exp Allergy 28 1998 1412 1417
39. Y. Hari, K. Frutig, and M. Hurni T cell involvement in cutaneous drug eruptions Clin Exp Allergy 31 2001 1398 1408
40. S. Watkins, and W.J. Pichler Activating interactions of sulfanilamides with T cell receptors Open J Immunol 3 2013 139 157
41. S. Watkins, and W.J. Pichler Sulfamethoxazole induces a switch mechanism in T cell receptors containing TCRV β20-1, altering pHLA recognition PLoS One 2013 in press
42. C.W. Yang, S.I. Hung, and C.G. Juo HLA-Bâ̂ - 1502 bound peptides: implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndrome J Allergy Clin Immunol 120 2007 870 877
43. T.M. Ko, W.H. Chung, and C.Y. Wei Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome J Allergy Clin Immunol 128 2011 1266 1276 e11
44. S. Mallal, D. Nolan, and C. Witt Association between presence of HLA-Bâ̂ - 5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir Lancet 359 2002 727 732
45. W.H. Chung, S.I. Hung, and H.S. Hong Medical genetics: a marker for Stevens-Johnson syndrome Nature 428 2004 486
46. S.I. Hung, W.H. Chung, and L.B. Liou HLA-Bâ̂ - 5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol Proc Natl Acad Sci U S A 102 2005 4134 4139
47. C. Lonjou, L. Thomas, and N. Borot A marker for Stevens-Johnson syndrome.: ethnicity matters Pharmacogenomics J 6 2006 265 268
48. D. Chessman, L. Kostenko, and T. Lethborg Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity Immunity 28 2008 822 832
49. S.J. Posadas, and W.J. Pichler Delayed drug hypersensitivity reactions - new concepts Clin Exp Allergy 37 2007 989 999
50. P. Schaerli, L. Ebert, and K. Willimann A skin-selective homing mechanism for human immune surveillance T cells J Exp Med 199 2004 1265 1275
51. J.H. Yearley, C. Pearson, A. Carville, R.P. Shannon, and K.G. Mansfield SIV-associated myocarditis: viral and cellular correlates of inflammation severity AIDS Res Hum Retroviruses 22 2006 529 540
52. B. Daubner, M. Groux-Keller, and O.V. Hausmann Multiple drug hypersensitivity: normal Treg cell function but enhanced in vivo activation of drug-specific T cells Allergy 67 2012 58 66
53. S. Sieben, Y. Kawakubo, T. Al Masaoudi, H.F. Merk, and B. Blömeke Delayed-type hypersensitivity reaction to paraphenylenediamine is mediated by 2 different pathways of antigen recognition by specific alphabeta human T-cell clones J Allergy Clin Immunol 109 2002 1005 1011
54. M. Keller, M. Lerch, and M. Britschgi Processing-dependent and -independent pathways for recognition of iodinated contrast media by specific human T cells Clin Exp Allergy 40 2009 257 268
55. N. Wuillemin, J. Adam, S. Fontana, S. Krähenbühl, W.J. Pichler, and D. Yerly HLA haplotype determines hapten or p-i T cell reactivity to flucloxacillin J Immunol 190 2013 4956 4964
56. B. Schnyder, C. Burkhart, and K. Schnyder-Frutig Recognition of sulfamethoxazole and its reactive metabolites by drug specific T cells from allergic individuals J Immunol 164 2000 6647 6654
57. J. Yun, J. Mattsson, and K. Schnyder Allopurinol hypersensitivity is primarily mediated by dose dependent oxypurinol-specific T cell response Clin Exp Allergy 2013 in press
58. B. Schnyder, J. Adam, A. Rauch, M. Thurnheer, and W.J. Pichler HLA-Bâ̂ - 57:011 abacavir-naive individuals have specific T cells but no patch test reactivity J Allergy Clin Immunol 132 2013 756 758
59. C.Y. Wei, W.H. Chung, H.W. Huang, Y.T. Chen, and S.I. Hung Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome J Allergy Clin Immunol 129 2012 1562 1569
60. M.M. Monshi, L. Faulkner, and A. Gibson Human leukocyte antigen (HLA)-Bâ̂ - 57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury Hepatology 57 2013 727 739
61. P. Chen, J.J. Lin, and C.S. Lu Carbamazepine-induced toxic effects and HLA-Bâ̂ - 1502 screening in Taiwan N Engl J Med 364 2011 1126 1133
62. S. Mallal, E. Phillips, and G. Carosi HLA-Bâ̂ - 5701 screening for hypersensitivity to abacavir N Engl J Med 358 2008 568 579